Search research articles
Contact Us
Filters
Showing results (191-200 of 208) with videos related to
Page
of 21
Sort By:
Journal of Leukocyte Biology
|
March 9, 2017
Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes
Rachel A Botting, Kirstie M Bertram, Heeva Baharlou, et al.
Plos Pathogens
|
April 27, 2021
Herpes Simplex Virus type 1 infects Langerhans cells and the novel epidermal dendritic cell, Epi-cDC2s, via different entry pathways
Kirstie M Bertram, Naomi R Truong, Jacinta B Smith, et al.
Frontiers in Immunology
|
September 27, 2021
Optimal Isolation Protocols for Examining and Interrogating Mononuclear Phagocytes From Human Intestinal Tissue
Chloe M Doyle, Erica E Vine, Kirstie M Bertram, et al.
Human Vaccines & Immunotherapeutics
|
February 19, 2021
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials
Joon Hyung Kim, John Diaz-Decaro, Ning Jiang, et al.
Plos Pathogens
|
June 26, 2024
Characterising plasmacytoid and myeloid AXL+ SIGLEC-6+ dendritic cell functions and their interactions with HIV
Freja A Warner van Dijk, Orion Tong, Thomas R O'Neil, et al.
Eclinicalmedicine
|
July 9, 2025
Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications
Ana Strezova, Javier Díez Domingo, Anthony L Cunningham, et al.
The Journal of Clinical Investigation
|
February 8, 2022
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells
Gabriel Duette, Bonnie Hiener, Hannah Morgan, et al.
The Journal of Infectious Diseases
|
March 13, 2018
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
Anthony L Cunningham, Thomas C Heineman, Himal Lal, et al.
Open Forum Infectious Diseases
|
June 5, 2026
Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years
Rafael Leon, Javier Diez-Domingo, Charles Andrews, et al.
Cell Reports
|
September 21, 2022
An in situ analysis pipeline for initial host-pathogen interactions reveals signatures of human colorectal HIV transmission
Heeva Baharlou, Nicolas Canete, Erica E Vine, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 208) with videos related to
Sort By:
Page
of 21
Journal of Leukocyte Biology
|
March 9, 2017
Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes
Rachel A Botting, Kirstie M Bertram, Heeva Baharlou, et al.
Plos Pathogens
|
April 27, 2021
Herpes Simplex Virus type 1 infects Langerhans cells and the novel epidermal dendritic cell, Epi-cDC2s, via different entry pathways
Kirstie M Bertram, Naomi R Truong, Jacinta B Smith, et al.
Frontiers in Immunology
|
September 27, 2021
Optimal Isolation Protocols for Examining and Interrogating Mononuclear Phagocytes From Human Intestinal Tissue
Chloe M Doyle, Erica E Vine, Kirstie M Bertram, et al.
Human Vaccines & Immunotherapeutics
|
February 19, 2021
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials
Joon Hyung Kim, John Diaz-Decaro, Ning Jiang, et al.
Plos Pathogens
|
June 26, 2024
Characterising plasmacytoid and myeloid AXL+ SIGLEC-6+ dendritic cell functions and their interactions with HIV
Freja A Warner van Dijk, Orion Tong, Thomas R O'Neil, et al.
Eclinicalmedicine
|
July 9, 2025
Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications
Ana Strezova, Javier Díez Domingo, Anthony L Cunningham, et al.
The Journal of Clinical Investigation
|
February 8, 2022
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells
Gabriel Duette, Bonnie Hiener, Hannah Morgan, et al.
The Journal of Infectious Diseases
|
March 13, 2018
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
Anthony L Cunningham, Thomas C Heineman, Himal Lal, et al.
Open Forum Infectious Diseases
|
June 5, 2026
Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years
Rafael Leon, Javier Diez-Domingo, Charles Andrews, et al.
Cell Reports
|
September 21, 2022
An in situ analysis pipeline for initial host-pathogen interactions reveals signatures of human colorectal HIV transmission
Heeva Baharlou, Nicolas Canete, Erica E Vine, et al.
Page
of 21